Human papilloma virus vaccine (Merck Sharp & Dohme)

人乳头状瘤病毒疫苗(默沙东)

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHuman papilloma virus vaccine (Merck Sharp & Dohme)
Drug Alias NameV-505
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVulvar NeoplasmsVaginal NeoplasmsUterine Cervical Neoplasms +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsVulvar NeoplasmsVaginal NeoplasmsUterine Cervical Neoplasms +[5

Other Information

ATC CodeN/A
Related LinksN/A